Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.14 USD | +0.47% | -1.88% | -69.80% |
18/04 | Immix Biopharma on Track to Dose First Patients with AL Amyloidosis Therapy by Mid-Year | MT |
18/04 | Immix Biopharma, Inc. Announces on Track to Dose NXC-201 Patients in United States | CI |
Official Publications
No official publication found
- Stock Market
- Equities
- IMMX Stock
- News Immix Biopharma, Inc.
- Official Publications